Sunflower Pharmaceutical Group (002737.SZ) Earnings Analysis
Sunflower Pharmaceutical Group (002737.SZ) has no confirmed upcoming earnings date. Trailing P/E -43.07.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002737.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 002737.SZ. This page updates as the calendar is published.
002737.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-04-25 | -0.16182 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.1 CNY | n/a | n/a | n/a |
| 2024-10-28 | 0.1721 CNY | n/a | n/a | n/a |
002737.SZ valuation and analyst view
| Trailing P/E | -43.07 |
|---|---|
| Trailing EPS | -0.35258 CNY |
| Price / book | 1.95 |
| Dividend yield | 1.50% |
| Market cap | 7.71B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sunflower Pharmaceutical Group (002737.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 002737.SZ. This page updates as the calendar is published.
Did 002737.SZ beat earnings last quarter?
Consensus estimate data was not available for 002737.SZ's 2025-04-25 report.
What is 002737.SZ's current P/E ratio and EPS?
002737.SZ trades at a trailing P/E of -43.07 on trailing EPS of -0.35257625478974686 CNY.
What do analysts rate 002737.SZ?
002737.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.